A detailed history of Creative Planning transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Creative Planning holds 16,061 shares of PRTA stock, worth $240,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,061
Previous 20,907 23.18%
Holding current value
$240,111
Previous $349,000 36.39%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$11.95 - $18.35 $57,909 - $88,924
-4,846 Reduced 23.18%
16,061 $222,000
Q3 2024

Oct 11, 2024

BUY
$16.73 - $24.79 $349,774 - $518,284
20,907 New
20,907 $349,000
Q1 2024

May 10, 2024

BUY
$24.75 - $40.66 $204,435 - $335,851
8,260 New
8,260 $204,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $701M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.